Beibei Zhang

机构：Yunnan University, First Affiliated Hospital of Henan University · ORCID：0000-0002-7231-360X

发表论文 8 篇 · 总被引 156 次 · h-index 6

代表论文

• Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside (2024 · Cell Death and Disease · 被引 66)
• Salvia miltiorrhiza Bunge extract and Przewalskin ameliorate Bleomycin-induced pulmonary fibrosis by inhibition of apoptosis, oxidative stress and collagen deposition via the TGF-β1 pathway (2024 · Phytomedicine · 被引 33)
• Forsythoside A regulates pulmonary fibrosis by inhibiting endothelial-to-mesenchymal transition and lung fibroblast proliferation via the PTPRB signaling (2024 · Phytomedicine · 被引 22)
• (−)-Epigallocatechin-3-gallate (EGCG) ameliorates ovalbumin-induced asthma by inhibiting inflammation via the TNF-α/TNF-R1/NLRP3 signaling pathway (2024 · International Immunopharmacology · 被引 19)
• Epimedium sagittatum Maxim ameliorates adriamycin‐induced nephropathy by restraining inflammation and apoptosis via the PI3K/AKT signaling pathway (2023 · Immunity Inflammation and Disease · 被引 9)
• Plantaginis Herba attenuates adriamycin-induced nephropathy: Molecular mechanism insights by integrated transcriptomic and experimental validation (2025 · Journal of Ethnopharmacology · 被引 7)